Higher Burden of Trichomonas vaginalis Infection in U.S. Blacks

Share this content:
Higher Burden of <i>Trichomonas vaginalis</i> Infection in U.S. Blacks
Higher Burden of Trichomonas vaginalis Infection in U.S. Blacks

FRIDAY, March 16, 2018 (HealthDay News) -- The burden of Trichomonas vaginalis (TV) infection is disproportionately high among blacks in the United States, according to a study published online March 15 in Clinical Infectious Diseases.

Eshan U. Patel, M.P.H., from Johns Hopkins University in Baltimore, and colleagues tested 4,057 males and females aged 18 to 59 years who participated in the 2013 to 2014 National Health and Nutrition Examination Survey and provided urine specimens for TV infection.

The researchers found that the prevalence of TV infection was 0.5 and 1.8 percent among males and females, respectively; 4.2 and 8.9 percent among black males and black females, respectively; and 0.03 and 0.8 percent among males and females of other races/ethnicities, respectively. There were positive associations for TV infection prevalence with female sex, black race, older age, being below the poverty level, and having two or more sexual partners. No TV and Chlamydia trachomatis co-infection was seen. There were no independent associations for genital human papillomavirus detection with TV infection. The relative racial disparity in TV infection was higher among persons age 18 to 39 years than the relative racial disparity of other sexually transmitted infections.

"There is a high and disproportionate burden of TV infection in the adult civilian, non-institutionalized black population in the United States that warrants intervention," the authors write.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

NIH Panel Will No Longer Review Gene Therapy Experiments

NIH Panel Will No Longer Review Gene Therapy ...

FDA will now assess gene therapy experiments and products as it does with other treatments, drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »